The Claim
Insulin promotes a shift in CD4+ T cells toward the pro-inflammatory Th17 phenotype and away from regulatory T cell populations in individuals with obesity and insulin resistance, contributing to sustained local inflammation.
What the research says
Not yet evaluated
We are still looking at what the research says.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In people with obesity and insulin resistance, insulin causes CD4+ T cells to become more pro-inflammatory Th17 cells and fewer regulatory T cells, resulting in ongoing local inflammation.
See the scientific wording
In the context of obesity and insulin resistance, insulin promotes a shift in CD4+ T cells toward the pro-inflammatory Th17 phenotype and away from regulatory T cell populations, contributing to sustained local inflammation.
High insulin levels in obese individuals cause fat cells to produce excess ceramides, which trigger inflammation and disrupt normal insulin signaling. This inflammatory environment forces immune cells called CD4+ T cells to become pro-inflammatory Th17 cells instead of calming Treg cells. The imbalance between these two cell types keeps inflammation going in fat tissue, which worsens insulin resistance.
What the research says
1 studyStudy: Molecular tracking of insulin resistance and inflammation development on visceral adipose tissue
In people with obesity and insulin resistance, high insulin levels make certain immune cells in fat tissue become more inflammatory and less calming, which keeps the inflammation going — and this study found exactly that.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.